Home › Results From the AMBITION Study of First-Line Treatment With Letairis...
 

Keywords :   


Results From the AMBITION Study of First-Line Treatment With Letairis...

2015-08-27 01:47:44| Biotech - Topix.net

Gilead Sciences, Inc. today announced detailed results from the AMBITION study . In AMBITION, conducted in collaboration with GlaxoSmithKline , combination therapy with Letairis and tadalafil reduced the risk of clinical failure by 50 percent compared to the pooled Letairis and tadalafil monotherapy arm .

Tags: with results study treatment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
04.10Should you tip even if the service wasn't worth it?
04.10Hurricane Kirk Graphics
04.10Hurricane Kirk Forecast Discussion Number 22
04.10Tropical Storm Leslie Forecast Discussion Number 10
04.10Hurricane Kirk Wind Speed Probabilities Number 22
04.10Hurricane Kirk Public Advisory Number 22
More »